3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
7
Salivary Gland Neoplasms
2
Prostate Adenocarcinoma
2
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
PSA Level Greater Than Two
1
Neoplasm Metastasis
1
Hormone Sensitive Prostate Cancer
1
HER2 Negative Breast Cancer
1
Castrate Sensitive Prostate Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms, Male
1
Advanced Breast Cancer
1
Interventions
spartalizumab
1
pembrolizumab
1
aldesleukin
1
Sunitinib
1
Interleukin-2
1
Blood Specimen Collection
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Diseases
×
Goserelin
×
90 days
×
Clear all
No trials found.